Correlation Between Biotechnology Portfolio and Us Government

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Biotechnology Portfolio and Us Government at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Biotechnology Portfolio and Us Government into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Biotechnology Portfolio Biotechnology and Us Government Securities, you can compare the effects of market volatilities on Biotechnology Portfolio and Us Government and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Biotechnology Portfolio with a short position of Us Government. Check out your portfolio center. Please also check ongoing floating volatility patterns of Biotechnology Portfolio and Us Government.

Diversification Opportunities for Biotechnology Portfolio and Us Government

0.56
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Biotechnology and RGVCX is 0.56. Overlapping area represents the amount of risk that can be diversified away by holding Biotechnology Portfolio Biotec and Us Government Securities in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Us Government Securities and Biotechnology Portfolio is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Biotechnology Portfolio Biotechnology are associated (or correlated) with Us Government. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Us Government Securities has no effect on the direction of Biotechnology Portfolio i.e., Biotechnology Portfolio and Us Government go up and down completely randomly.

Pair Corralation between Biotechnology Portfolio and Us Government

Assuming the 90 days horizon Biotechnology Portfolio Biotechnology is expected to under-perform the Us Government. In addition to that, Biotechnology Portfolio is 5.49 times more volatile than Us Government Securities. It trades about -0.21 of its total potential returns per unit of risk. Us Government Securities is currently generating about -0.37 per unit of volatility. If you would invest  1,196  in Us Government Securities on October 6, 2024 and sell it today you would lose (24.00) from holding Us Government Securities or give up 2.01% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Biotechnology Portfolio Biotec  vs.  Us Government Securities

 Performance 
       Timeline  
Biotechnology Portfolio 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Biotechnology Portfolio Biotechnology has generated negative risk-adjusted returns adding no value to fund investors. In spite of latest weak performance, the Fund's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the fund investors.
Us Government Securities 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Us Government Securities has generated negative risk-adjusted returns adding no value to fund investors. In spite of fairly strong fundamental indicators, Us Government is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Biotechnology Portfolio and Us Government Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Biotechnology Portfolio and Us Government

The main advantage of trading using opposite Biotechnology Portfolio and Us Government positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Biotechnology Portfolio position performs unexpectedly, Us Government can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Us Government will offset losses from the drop in Us Government's long position.
The idea behind Biotechnology Portfolio Biotechnology and Us Government Securities pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.

Other Complementary Tools

Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Stocks Directory
Find actively traded stocks across global markets
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk